NMSG8 – Aredia Myelom – The effect of i.v. bisphosphonate on health-related quality of life and skeletal morbidity for newly diagnosed treatment demanding multiple myeloma. A prospective randomised double blinded dose-effective study with cost-utility analysis. Start year: 2001
NMSG8 – Aredia Myelom Official title: The effect of i.v. bisphosphonate on health-related quality of life and skeletal morbidity for newly diagnosed treatment demanding multiple myeloma. A prospective randomised double blinded dose-effective study with cost-utility analysisTrial start year: 2001 Trial websiteNo website available Trial registrationNCT00376883View registration Design paperNo design paper published Result paper2010Eff ect of …